What Akoya Biosciences, Inc.'s executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 0 |
| Sells | 0 | 0 |
| Total trades | 0 | 0 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 0 | 0 |
| Disposed | 0 | 0 |
| Net activity | +0 | +0 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Kamocsay Jennifer | Chief Legal Officer | Jul 08 | Other Transaction · J | −162,500 | — | — | 0 |
| Kamocsay Jennifer | Chief Legal Officer | Jul 08 | Other Transaction · J | −16,772 | — | — | 162,500 |
| Mendel Scott | Director | Jul 08 | Other Transaction · J | −28,500 | — | — | 0 |
| Lai Goldman Myla | Director | Jul 08 | Other Transaction · J | −20,000 | — | — | 0 |
| Raffin Thomas A. | Director | Jul 08 | Other Transaction · J | −15,937,535 | — | — | 0 |
| Raffin Thomas A. | Director | Jul 08 | Other Transaction · J | −1,737,712 | — | — | 0 |
| Raffin Thomas A. | Director | Jul 08 | Other Transaction · J | −234,592 | — | — | 0 |
| Winkler Matthew | Director | Jul 08 | Other Transaction · J | −984,513 | — | — | 0 |
| Bamford Pascal | Chief Clinical Officer | Jul 08 | Other Transaction · J | −196,250 | — | — | 0 |
| Bamford Pascal | Chief Clinical Officer | Jul 08 | Other Transaction · J | −9,488 | — | — | 196,250 |
| Ek John Frederick | CFO | Jul 08 | Other Transaction · J | −20,000 | — | — | 0 |
| Ek John Frederick | CFO | Jul 08 | Other Transaction · J | −193,750 | — | — | 0 |
| Ek John Frederick | CFO | Jul 08 | Other Transaction · J | −54,452 | — | — | 193,750 |
| McKelligon Brian | President and CEO | Jul 08 | Other Transaction · J | −947,688 | — | — | 0 |
| McKelligon Brian | President and CEO | Jul 08 | Withheld — tax / exercise cost · F | −196,866 | — | — | 947,688 |
| McKelligon Brian | President and CEO | Jul 08 | Other Transaction · J | +331,090 | — | — | 1,144,554 |
| McKelligon Brian | President and CEO | Jul 08 | Other Transaction · J | +393,338 | — | — | 813,464 |
| Ramachandran Niro Ph.D | Chief Business Officer | Jul 08 | Other Transaction · J | −130,625 | — | — | 0 |
| Ramachandran Niro Ph.D | Chief Business Officer | Jul 08 | Other Transaction · J | −151,930 | — | — | 130,625 |
| Ramachandran Niro Ph.D | Chief Business Officer | Jul 08 | Withheld — tax / exercise cost · F | −42,148 | — | — | 282,555 |
Loading...